Zurcher Kantonalbank Zurich Cantonalbank Has $386,000 Stock Position in Trupanion, Inc. (NASDAQ:TRUP)

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP) by 13.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 10,354 shares of the financial services provider’s stock after buying an additional 1,214 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Trupanion were worth $386,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. American Century Companies Inc. acquired a new stake in shares of Trupanion in the fourth quarter valued at approximately $1,111,000. Sei Investments Co. raised its holdings in shares of Trupanion by 36.1% in the fourth quarter. Sei Investments Co. now owns 6,818 shares of the financial services provider’s stock valued at $329,000 after purchasing an additional 1,810 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Trupanion by 458.3% in the fourth quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider’s stock valued at $7,620,000 after purchasing an additional 129,782 shares during the last quarter. Pictet Asset Management Holding SA acquired a new stake in shares of Trupanion in the fourth quarter valued at approximately $242,000. Finally, Wells Fargo & Company MN raised its holdings in shares of Trupanion by 44.1% in the fourth quarter. Wells Fargo & Company MN now owns 15,798 shares of the financial services provider’s stock valued at $761,000 after purchasing an additional 4,836 shares during the last quarter.

Trupanion Stock Performance

Shares of TRUP stock opened at $48.81 on Friday. The stock has a market cap of $2.09 billion, a P/E ratio of 187.74 and a beta of 1.78. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.70 and a quick ratio of 1.70. The company has a fifty day moving average price of $51.11 and a two-hundred day moving average price of $44.02. Trupanion, Inc. has a one year low of $31.00 and a one year high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.25. The firm had revenue of $353.56 million during the quarter, compared to analysts’ expectations of $346.73 million. Trupanion had a net margin of 0.81% and a return on equity of 3.38%. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter last year, the company posted ($0.14) earnings per share. As a group, equities analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Insider Buying and Selling at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 2,534 shares of Trupanion stock in a transaction on Thursday, May 29th. The shares were sold at an average price of $48.31, for a total transaction of $122,417.54. Following the completion of the transaction, the chief financial officer directly owned 3,545 shares of the company’s stock, valued at $171,258.95. The trade was a 41.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total transaction of $183,440.00. Following the transaction, the chief executive officer directly owned 118,784 shares of the company’s stock, valued at approximately $5,447,434.24. This trade represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,562 shares of company stock worth $544,870 over the last quarter. 5.42% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on TRUP. Stifel Nicolaus lifted their price objective on shares of Trupanion from $41.00 to $45.00 and gave the company a “hold” rating in a report on Friday. Piper Sandler lifted their price objective on shares of Trupanion from $62.00 to $67.00 and gave the company an “overweight” rating in a report on Friday. Finally, Lake Street Capital lowered their price objective on shares of Trupanion from $65.00 to $60.00 and set a “buy” rating on the stock in a report on Friday, May 2nd. Two investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $55.60.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.